Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-034177
Filing Date
2024-03-20
Accepted
2024-03-20 16:15:10
Documents
1
Period of Report
2024-03-18

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4054
  Complete submission text file 0000950170-24-034177.txt   5497
Mailing Address C/O TETRAPHASE PHARMACEUTICALS, INC. 480 ARSENAL STREET, SUITE 110 WATERTOWN MA 02472
Business Address
Horn Patrick Taylor (Reporting) CIK: 0001572002 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38978 | Film No.: 24767968

Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Issuer) CIK: 0001680581 (see all company filings)

EIN.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)